STOK: Stoke Therapeutics, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 2 sales totaling $44K in the last 180 days.
Insider sales
| Trade date | Insider | Role | Value | 10b5-1 plan |
|---|---|---|---|---|
| 2026-10-02 | Allan Jonathan | Officer | $17K | yes |
| 2026-10-01 | Ticho Barry | Officer | $27K | yes |
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-09-30 | New 13G stake | BIOTECHNOLOGY VALUE FUND L P | 5.60% | SEC | |
| 2026-08-14 | 13G amendment | Lynx1 Capital Management LP | 6.50% | SEC | |
| 2026-08-06 | 13G amendment | FMR LLC | 8.50% | SEC |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.